GlaxoSmithKline | GSK - Assets

Stock Price
2,121.50
Daily Change
41.50 2.00%
Monthly
11.69%
Yearly
43.39%
Q1 Forecast
1,839.16

GlaxoSmithKline reported GBP61.12B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 133.9B 3.28B Sep/2025
Alcon AG USD 31.52B 137M Sep/2025
Almirall EUR 2.31B 88.74M Jun/2025
Amgen USD 90.14B 2.24B Sep/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.46B 2.03B Sep/2025
Bayer EUR 104.21B 1.03B Sep/2025
Biogen USD 29.21B 877.3M Sep/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Eli Lilly USD 114.94B 14.01B Sep/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Fresenius Medical Care EUR 30.89B 404.18M Sep/2025
Galapagos EUR 3.51B 306.31M Sep/2025
Genmab DKK 6.46B 122M Jun/2025
Gilead Sciences USD 58.53B 2.81B Sep/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Glaxosmithkline GBP 82.45B 23.19B Sep/2025
GRIFOLS EUR 19.85B 86.61M Sep/2025
Hikma Pharmaceutical USD 5.55B 421M Jun/2025
Lonza CHF 19.73B 1.85B Dec/2024
Merck EUR 50.93B 3.58B Sep/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Orion EUR 1.75B 102.1M Sep/2025
Pfizer USD 208.73B 2.64B Sep/2025
Philips EUR 26.34B 40M Sep/2025
Recordati EUR 5.3B 122.58M Sep/2025
Regeneron Pharmaceuticals USD 40.56B 389.3M Dec/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Smith & Nephew USD 10.69B 150M Dec/2025
UCB EUR 17.35B 1.72B Dec/2024